Patent details

Herbas

VPB

Print

EN | LT

LT - A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA

EN - A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/10
		A61K 31/513
		A61P 35/02

European patent
(11)	Number of the document	2978439
(13)	Kind of document	T
(96)	European patent application number	14717212.6
	Date of filing the European patent application	2014-03-19
(97)	Date of publication of the European application	2016-02-03
(45)	Date of publication and mention of the grant of the patent	2017-08-16
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IL2014/050303
	Date	2014-03-19

PCT application publication
(87)	Number	WO 2014/155376
	Date	2014-10-02

Priority applications
(30)	Number	Date	Country code
	201361804677 P	2013-03-24	US

Inventors
(72)	PELED, Amnon, IL PEREG, Yaron, IL

Grantee
(73)	Biokine Therapeutics Ltd., Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona, IL BIOLINERX LTD., 2 HaMaayan Street, 7177871 Modiln, IL

Title
(54)	A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA
	A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA